Evidence map›Paper›PMID 25562595›Full record

ArticleJournal of personalized medicine2011

Developing drugs for children and the adjustment of medication-is it a new challenge or an adaptation of past ideas?

Pascale Gauthier, Jean-Michel Cardot

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Physiological bio-distribution ofAnnals of nuclear medicine · 2025
    Article
  3. Molecular investigation of human metapneumovirus in children with acute respiratory infections in Chennai, South India, from 2016-2018.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  4. Article
  5. Paracetamol as a toxic substance for children: aspects of legislation in selected countries.Journal of occupational medicine and toxicology (London, England) · 2015
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pascale GauthierUniversity Clermont 1, UFR Pharmacie, Biopharmaceutical Department, 28, Place H. Dunant, B.P. 38, F-63001 Clermont-Ferrand, France. Pascale.Gauthier@u-clermont1.fr.
Jean-Michel CardotUniversity Clermont 1, UFR Pharmacie, Biopharmaceutical Department, 28, Place H. Dunant, B.P. 38, F-63001 Clermont-Ferrand, France. J-Michel.CARDOT@u-clermont1.fr.
Université Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays the adjustment of medication for each patient is at the center of health strategy. Children can be considered as specific targets with their own specificities. In the oral route field some examples of drugs especially adapted to children can be found. Design is introduced in drug formulation to offer a better choice of products and now, children can be considered as partners in their own treatment. Enhanced comprehension of children's requirements can also lead to creation of drugs that improve compliance.

Identifiers

PMID25562595
PMCPMC4251352
OpenAlexW2102480705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.